How big is the Locally Advanced Pancreatic Cancer Market ?
Global Locally Advanced Pancreatic Cancer market reached USD 0.9 billion in 2022 and is expected to reach USD 2.0 billion by 2030.
Who are the key players in Locally Advanced Pancreatic Cancer Market ?
Major players are Merck & Co., Inc, Bristol-Myers Squibb Company, Getwell, Ipsen, Biopharmaceuticals, Inc., Novartis Pharmaceuticals Corporation, Pfizer, Bayer HealthCare Pharmaceuticals, Inc., Genentech USA, Inc, and AstraZeneca.